Adhesive patch

A patch, polymer technology, applied in the directions of non-active ingredients medical preparations, urinary system diseases, organic active ingredients, etc., can solve the problems of low drug absorption, slow drug absorption rate, low solubility, etc. , the effect of improving skin penetration

Inactive Publication Date: 2004-05-26
HISAMITSU PHARM CO INC
View PDF0 Cites 11 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

For example, although rubber-based polymers with relatively low drug solubility have high transdermal absorbability of drugs, the amount of drug that can be contained is limited, so the rate of drug absorption tends to decrease during sticking, and as a result, the blood drug concentration sometimes decreases. Unable to obtain sustained effect (New Drugs and Clinics, 48, 1015-1-24, 1993)
In addition, rubber-based polymers tend to cause crystallization of the drug in the preparation over time due to low solubility of the drug, and sufficient stability may not be obtained in some cases.
[0006] In addition, although acrylic polymers have higher drug solubility than rubber-based polymers, drug absorption is low
Therefore, in order to obtain the necessary drug absorption in a patch using an acrylic polymer, it is necessary to increase the concentration of the drug, so that sufficient physical properties of the preparation may not be obtained or the cost may increase during preparation.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0057] (making of patch)

[0058] Mix sertraline, pyrothiodecane, and liquid paraffin thoroughly in a mortar and pestle. Add this mixture to an acrylic polymer (2-ethylhexyl acrylate / vinyl acetate copolymer) made of styrene-isoprene-styrene block copolymer, substantially free of carboxyl and hydroxyl groups, ester A coating solution having the following composition was prepared from a mixed solution consisting of a cyclic saturated hydrocarbon resin (Alcon P-100, manufactured by Arakawa Chemical Industry Co., Ltd.), ethyl acetate, and toluene.

[0059] Styrene-isoprene-styrene block copolymer 20.0%

[0060] Acrylic polymer 10.0%

[0061] Alicyclic saturated hydrocarbon resin 32.0%

[0062] Liquid paraffin 30.0%

[0063] Pyrothiodecane 3.0%

[0064] Sertraline 5.0%

[0065] Then, the obtained coating solution is coated on release paper made of polyethylene terephthalate, and the solvent is removed by drying to form a film of the adhesive layer, and then the polyethylene t...

Embodiment 2-1

[0077] Take sertraline hydrochloride, coke thiodecane, sodium acetate, acetic acid and liquid paraffin and mix thoroughly in a mortar. Add this compound to polyisobutylene, acrylic polymer (2-ylhexyl acrylate / vinyl acetate copolymer) that does not have carboxyl group and hydroxyl group substantially, hydrogenated rosin ester (ester gum H, manufactured by Arakawa Chemical Industry Co., Ltd. ), ethyl acetate, and toluene, a coating solution having the composition shown below was prepared.

[0078] Polyisobutylene 20.0%

[0079] Acrylic polymer 10.0%

[0080] Hydrogenated rosin ester 28.0%

[0081] Liquid paraffin 28.0%

[0082] Pyrothiodecane 3.0%

[0083] Sodium acetate 3.0%

[0084] Acetic acid 3.0%

[0085] Sertraline Hydrochloride 5.0%

[0086] Then, apply the obtained coating solution on release paper made of polyethylene terephthalate, dry and remove the solvent to form a film of the adhesive layer, and then bond polyethylene terephthalate to the adhesive layer. Et...

Embodiment 2-2

[0089] A patch was prepared in the same manner as in Example 2-1, except that a styrene-isoprene-styrene block copolymer was used instead of the polyisobutylene in Example 2-1.

[0090] The prepared patch was subjected to a skin penetration test and a preparation physical property test in the same manner as in Example 1. The obtained results are shown in Table 2.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

A patch agent of the present invention comprises a support, and an adhesive layer laid on the support and containing an adhesive base and a drug, wherein the adhesive base contains an acrylic polymer substantially having no carboxyl and no hydroxyl in molecules thereof, and a rubber-based polymer, so as to achieve sufficiently high skin permeability of the drug and preparation properties. Accordingly, the present invention enables administration of the drug through skin to be implemented with drug administration effect at a sufficiently high level and on a stable basis.

Description

technical field [0001] The present invention relates to a patch, and more specifically, to a patch using an acrylic polymer and a rubber-based polymer as an adhesive matrix. Background technique [0002] Oral administration using tablets, capsules, syrups, etc. has been known in the past as methods for administering drugs, but in recent years attempts have been made to administer these drugs using patches. The administration method using patches not only solves the problems in the oral method, but also has the advantages of reducing the frequency of administration, improving compliance, and being easy to administer or stop administration, so it is particularly expected as a drug for the elderly or children. medicine law. [0003] However, the stratum corneum of normal skin has a barrier function to prevent foreign substances from invading the body, and the medicinal ingredients usually mixed in the matrix of the patch cannot obtain sufficient transdermal absorption in most ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/70A61K31/216A61K31/48A61K47/32
CPCA61K31/48A61K31/216A61K9/7053A61K9/7061A61K47/32A61K9/7076A61P13/00A61P25/16A61K9/70
Inventor 立石哲郎寺原孝明肥后成人
Owner HISAMITSU PHARM CO INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products